Istituto Oncologico Veneto IRCCS
Quick facts
Marketed products
- Local Standard of Care · Oncology
Local Standard of Care refers to the established treatment protocols and therapeutic approaches used at Istituto Oncologico Veneto IRCCS for cancer management, which vary by tumor type and patient characteristics.
Phase 3 pipeline
- MSB0010718C · Oncology
MSB0010718C is a therapeutic cancer vaccine designed to activate the immune system against tumor-associated antigens.
Phase 2 pipeline
- Adjuvant Hormone Therapy · Oncology
Adjuvant Hormone Therapy involves the use of hormone-blocking medications to prevent the growth and spread of cancer cells. - Anti-B-RAF · Oncology
Anti-B-RAF drugs target and inhibit the B-Raf protein, which is often mutated in cancer cells. - SAMITAL®
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: